In her first breakthrough.

One of the reasons that coffee has a high level of caffeine that is synthesized in the plant, caffeine very quickly, but interrupts the theophylline very slowly. We know that there is an enzyme that breaks down caffeine to theophylline, but we do not know much about them, says Gallivan, assistant professor of chemistry. What we know is that it is very slow work. Ideally we would like to speed it up a little bit, so that we create coffee plants that could arm of caffeine. This is where the bacteria come in now need the breakdown product of the enzyme theophylline theophylline) for survival, but they can not do much with caffeine.

Emory develop bacteria that help decaffeinate coffee canchemists at Emory University , have an important advance in the use of the ability of bacteria to make new molecules have made, and their discovery could eventually to the creation of naturally decaffeinated coffee plant cause. The study, to Emory chemist Justin Gallivan and graduate student Shawn Desai, in the 27th October issue of the Journal of the American Chemical Society appear.Researchers figured out to earlier preclinical research to flavopiridol significantly increases to anti-cancer effects cisplatin and later on performed a phase I clinical driver trial to combination of for patients complete responses and five others patients had partial response . The 33 % of overall response rate be as twice as high as seen with standard chemotherapy.. In this study, researchers combined therapy with flavopiridol with cisplatin reviewed on female to board – resistant ovarian cancer and the primary peritoneal cancers.